91 Startups
  • Sector
  • Participated in
  • Year of participation

KimerDx

  • 2013
  • Diagnostics
  • Venture Challenge
Molecular diagnostics products for chimerisme monitoring

Levels Diagnostics

  • 2019
  • Diagnostics
  • Venture Challenge
Levels Dx is using activated immune cells as biomarkers to allow an accurate diagnosis of a bacterial infection in patients. The products developed are a FACS immunoassay (to be used in the hospital setting), followed by the development of a rapid diagnostic tool (to be used at the primary care setting). The Rapid Diagnostic Tool (RDT) will provide accurate results within minutes and is portable.

Mantis Therapeutics

  • 2016
  • Therapeutics
  • Venture Challenge
Developing an innovative targeted immunotherapy against cancer using remote controlled conditional attenuated bacteria.

MAXAM Medical

  • 2009
  • Medical Device
  • Venture Challenge
Diagnostic and treatment device for pelvic floor dysfunctions, such as prolapse, micturition, defecation and urinary and faecal incontinence

MedicalVR

  • 2020
  • Medical Device
  • Venture Challenge
MedicalVR’s PulmoVR innovation enables thoracic surgeons to cure patients with lung cancer by preventing the unnecessary removal of healthy lung tissue, resulting in a ‘lung-sparing surgical procedure’ for lung cancer.

Mercurna

  • 2016
  • Therapeutics
  • Venture Challenge
We firmly believe that everybody has the basic human right to live without the limitations of disease. Therefore, we aim to provide patients with new treatment options that add true value and allow them to break free from those limitations.

Mission MS

  • 2019
  • Therapeutics
  • Venture Challenge
From Genes to Pathways to Novel Drugs For Multiple Sclerosis

Momo Medical

  • Medical Device
  • Venture Challenge
Preventing pressure ulcers with smart monitoring

MULTISCREENING

  • 2019
  • Enabling Technology
  • Venture Challenge
At Multiscreening, we developed a patented technology to introduce High Throughput Screening (HTS) for in vivostudies, allowing our customers to increase patent protected market sales by 4 months for each animal experimental series being performed.